Skip to content

Introduction of a breast cancer care programme in ultra short stay (ambulatory/24 stay setting) in 4 early adopter centres: implementation and evaluation.

Introduction of a breast cancer care programme in ultra short stay (ambulatory/24 stay setting) in 4 early adopter centres: implementation and evaluation.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON20135
Enrollment
400
Registered
2005-09-15
Start date
2004-12-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

A comprehensive care programme for breast cancer surgery in ultra short stay
in 4 early adopter hospitals.

Sponsors

ZonMw PO Box 93245 2509 AE Den Haag T 070 349 5111 F 070 349 5100 info@zonmw.nl
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Breast cancer patients of all ages undergoing all types of surgical interventions for breast cancer.

Exclusion criteria

Exclusion criteria: Contraindications are those related to the physiology of the patient, and therefore not age or any of the surgery types employed in the treatment of breast cancer.

Design outcomes

Primary

MeasureTime frame
Percent patients in ultra short stay, - percent patients treated according to protocol, - cost-effectiveness of the care programme and implementation programme.

Secondary

MeasureTime frame
1. Patient satisfaction; 2. Degree of involvement of home care nursing); Process indicators: a. access time to out patient department, b. time spent in the diagnostic process, c. access time to the surgical procedure, d. surgical quality of care (complications, nr of re-operations), e. patient satisfaction.

Contacts

Public ContactM.F. Meyenfeldt

University Hospital Maastricht, Departement of Surgery, P.O. Box 5800

mf.vonmeyenfeldt@ah.unimaas.nl+31 (0)43 3877478

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)